/
ASH
$64.23+$0.29 (+0.45%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.9B
46M shares
52-week range
$46.30 – $68.26
82% from low
Sector
WHOLESALE-CHEMICALS & ALLIED PRODUCTS
Exchange
NYSE
CS
Borrow rate
0.42%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-23.93
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.59B | $2.15B | $2.02B | $2.11B | $2.39B | $2.19B | $2.11B | $1.82B |
| Cost of revenue | $1.73B | $1.50B | $1.42B | $1.44B | $1.56B | $1.52B | $1.50B | $1.27B |
| Gross profit | $863.0M | $651.0M | $599.0M | $670.0M | $830.0M | $668.0M | $618.0M | $549.0M |
| Gross margin | 33.3% | 30.3% | 29.7% | 31.7% | 34.7% | 30.5% | 29.2% | 30.1% |
| R&D | $73.0M | $58.0M | $56.0M | $50.0M | $55.0M | $51.0M | $55.0M | $54.0M |
| Operating income | $102.0M | $86.0M | −$461.0M | $192.0M | $333.0M | $172.0M | −$26.0M | −$775.0M |
| EBITDA | $404.0M | $382.0M | −$254.0M | $448.0M | $509.0M | $457.0M | $303.0M | −$509.0M |
| Net income | $114.0M | $505.0M | −$508.0M | $220.0M | $927.0M | $178.0M | $169.0M | −$845.0M |
| Net margin | 4.4% | 23.5% | -25.2% | 10.4% | 38.8% | 8.1% | 8.0% | -46.3% |
| EPS (diluted) | 1.78 | 8.03 | -8.39 | 3.66 | 16.41 | 3.31 | 3.38 | -18.37 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.9B | $3.60 | $3.14–$3.87 | 6 |
| 2027 | $1.9B | $4.31 | $3.64–$4.72 | 6 |
| 2028 | $2.0B | $4.84 | $4.08–$5.60 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$47.60
Price
$64.23
Implied downside
-26%
Peer comparison
Ashland Inc.
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
www.ashland.com- Employees
- 2,900
- IPO / List date
- May 8, 1950
- HQ
- WILMINGTON, DE
Held by traders on TradeandTell
No one on the platform currently holds ASH.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 91,775 | $6.6M |
| Bridgewater Associatesas of 2026-03-31 | 23,974 | $1.3M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.59% ($1.67/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-01 | $0.4200 | 2026-06-15 |
| 2026-02-27 | $0.4150 | 2026-03-15 |
| 2025-12-01 | $0.4150 | 2025-12-15 |
| 2025-08-29 | $0.4150 | 2025-09-15 |
| 2025-05-30 | $0.4150 | 2025-06-15 |
| 2025-02-28 | $0.4050 | 2025-03-15 |
| 2024-11-29 | $0.4050 | 2024-12-15 |
| 2024-08-30 | $0.4050 | 2024-09-15 |
| 2024-05-31 | $0.4050 | 2024-06-15 |
| 2024-02-29 | $0.3850 | 2024-03-15 |
Recent trades on TradeandTell
No one on the platform has traded ASH yet.
